1 |
Blake KS, Choi J, Dantas G. Approaches for characterizing and tracking hospital-associated multidrug-resistant bacteria.[J]. Cell Molecul Life Sci: CMLS, 2021, DOI: 10.1007/s00018-020-03717-2.
|
2 |
中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志,2018, 41(4): 255-280.
|
3 |
Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society[J]. Clin Infect Dis, 2016, 63(5): e61-e111.
|
4 |
Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT)[M]. 2017. 10.1183/13993003.00582-2017.
|
5 |
Kelly DN, Martin-Loeches I. Comparing current US and European guidelines for nosocomial pneumonia[J]. Curr Opin Pulm Med, 2019, 25(3): 263-270.
|
6 |
Wang Q, Wang Z, Zhang F, et al. Long-term continuous antimicrobial resistance surveillance among nosocomial gram-negative bacilli in China from 2010 to 2018 (CMSS)[J]. Infect Drug Resist, 2020,13: 2617-2629.
|
7 |
Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.[J]. Am J Resp Crit Care, 2011, 184(12): 1409-1417.
|
8 |
Xie J, Yang Y, Huang Y, et al. The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: A multicenter prospective observational study in China.[J]. Clin Infect Dis, 2018, 67: S153-S161.
|
9 |
Yin Y, Zhao C, Li H, et al. Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(4): 683-690.
|
10 |
胡必杰,何礼贤,詹雪妹,等. 痰培养标本质量评估的量化标准探讨——14 001次痰细胞学检查与细菌培养结果的比较研究[J]. 中华微生物学和免疫学杂志,2001,(S1): 36-39.
|
11 |
Clinical and Laboratory Standards Institute. performance standards for antimicrobial susceptibility testing[S]. Twenty-sixth Informational Supplement, 2016, M100S, 26th ed.
|
12 |
Clinical and Laboratory Standards Institute. performance standards for antimicrobial susceptibility testing[S]. Twenty-seventh Informational Supplement, 2017, M100S, 27th ed.
|
13 |
Clinical and Laboratory Standards Institute. performance standards for antimicrobial susceptibility testing[S]. Twenty-eighth Informational Supplement, 2018, M100S, 28th ed.
|
14 |
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J]. Clin Microbiol Infect, 2012, 18(3): 268-281.
|
15 |
Hawkey PM, Warren RE, Livermore DM, et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.[J]. J Antimicr Chemoth, 2018,73: iii2-iii78.
|
16 |
Martin-Loeches I, Rodriguez AH, Torres A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.[J]. Curr Opin Crit Care, 2018, 24(5): 347-352.
|
17 |
Sader HS, Castanheira M, Mendes RE, et al. Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)[J]. J Antimicrob Chemother, 2018, 73(11): 3053-3059.
|
18 |
刘又宁,曹 彬,王 辉,等. 中国九城市成人医院获得性肺炎微生物学与临床特点调查[J]. 中华结核和呼吸杂志,2012, 35(10): 739-746.
|
19 |
刘 佳,刘泽秀,王 伟,等. 老年患者医院获得性肺炎的病原菌及耐药性探讨[J]. 中华医院感染学杂志,2013, 23(10): 2481-2483.
|
20 |
陈宏斌,赵春江,王 辉,等. 2007-2013年医院内获得性肺炎病原菌分布及其耐药性分析[J]. 中华医院感染学杂志,2017, 27(1): 1-7,15.
|
21 |
杨 敏,谢集建,陈 炜. 十堰地区婴幼儿社区获得性肺炎常见病原体致病情况及耐药性变迁分析[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(6): 737-741.
|
22 |
肖 婕,黎 莉,邓智全,等. 老年慢性心衰住院患者医院获得性肺炎的病原菌及其影响因素[J]. 中华医院感染学杂志,2020, 30(1): 72-76.
|
23 |
胡付品,郭 燕,朱德妹,等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志,2020, 20(1): 1-10.
|
24 |
胡付品,郭 燕,朱德妹,等. 2019年CHINET三级医院细菌耐药监测[J]. 中国感染与化疗杂志,2020, 20(3): 233-243.
|
25 |
2018年全国细菌耐药监测报告[J]. 中国合理用药探索,2020, 17(1): 1-10.
|
26 |
Gales AC, Seifert H, Gur D, et al. Acinetobacter calcoaceticus-acinetobacter baumannii antimicrobial susceptibility of complex and clinical Isolates: results from the SENTRY antimicrobial surveillance program (1997-2016).[J]. Open Forum Infect Di, 2019, 6: S34-S46.
|
27 |
Petraitis V, Petraitiene R, Naing E, et al. Ceftolozane-tazobactam in the treatment of experimental pseudomonas aeruginosa pneumonia in persistently neutropenic rabbits: impact on strains with genetically defined mechanisms of resistance.[J]. Antimicrob Agents Ch, 2019, 63(9): DOI: 10.1128/AAC.00344-19.
|
28 |
王 楠,薛 婧,朱少静,等. 2017-2018年某院分离114株嗜麦芽窄食单胞菌的耐药性分析[J]. 中国医院药学杂志,2019, 39(17): 1800-1803.
|
29 |
杨子林,陈 键. 老年呼吸疾病住院患者嗜麦芽窄食单胞菌感染及耐药情况分析[J]. 广西医学,2019, 41(2): 229-232, 237.
|
30 |
石 磊,吴安华,曹 岚,等. 重症监护病房嗜麦芽窄食单胞菌医院感染的危险因素[J]. 中国感染控制杂志,2019, 18(5): 403-409.
|
31 |
Guerci P, Bellut H, Mokhtari M, et al. Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study[J]. Crit Care, 2019, 23(1): 371.
|